Total Payments
$116,428
2024 Payments
$9,240
Companies
33
Transactions
492
Medicare Patients
2,676
Medicare Billing
$153,605
Payment Breakdown by Category
Other$84,454 (72.5%)
Travel$14,971 (12.9%)
Consulting$8,674 (7.4%)
Food & Beverage$8,067 (6.9%)
Education$262.66 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $84,454 | 52 | 72.5% |
| Travel and Lodging | $14,971 | 32 | 12.9% |
| Consulting Fee | $8,674 | 5 | 7.4% |
| Food and Beverage | $8,067 | 394 | 6.9% |
| Education | $262.66 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $101,662 | 265 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $11,419 | 33 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $632.98 | 30 | $0 (2022) |
| GlaxoSmithKline, LLC. | $351.03 | 24 | $0 (2023) |
| Gilead Sciences, Inc. | $310.52 | 12 | $0 (2023) |
| Lilly USA, LLC | $301.35 | 22 | $0 (2023) |
| AbbVie Inc. | $235.10 | 17 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $213.64 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $200.02 | 14 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $143.01 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,240 | 16 | Novo Nordisk Inc ($9,189) |
| 2023 | $10,537 | 55 | Novo Nordisk Inc ($8,467) |
| 2022 | $48,691 | 196 | Novo Nordisk Inc ($37,300) |
| 2021 | $27,273 | 57 | Novo Nordisk Inc ($26,997) |
| 2020 | $11,576 | 46 | Novo Nordisk Inc ($11,474) |
| 2019 | $8,372 | 55 | Novo Nordisk Inc ($7,948) |
| 2018 | $487.66 | 42 | Novo Nordisk Inc ($169.95) |
| 2017 | $251.12 | 25 | Novo Nordisk Inc ($117.25) |
All Payment Transactions
492 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $580.00 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $580.00 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $580.00 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Oncology | ||||||
| 04/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,358.50 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $580.00 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $580.00 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $580.00 | General |
| Category: Diabetes | ||||||
| 01/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 11/17/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Consulting Fee | Cash or cash equivalent | $1,316.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,972.50 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $1,059.74 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $481.88 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $339.01 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $79.27 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $53.71 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $36.93 | General |
| Category: Diabetes | ||||||
| 10/06/2023 | Stryker Corporation | — | Food and Beverage | In-kind items and services | $83.33 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 148 | 231 | $37,638 | $17,814 |
| 2022 | 8 | 292 | 379 | $36,597 | $25,655 |
| 2021 | 21 | 1,192 | 1,585 | $137,486 | $57,387 |
| 2020 | 23 | 1,044 | 1,546 | $144,808 | $52,749 |
Total Patients
2,676
Total Services
3,741
Medicare Billing
$153,605
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 132 | $23,280 | $11,017 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 36 | $4,605 | $2,285 | 49.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,353 | $2,222 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $3,153 | $2,131 | 67.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 19 | $247.00 | $159.60 | 64.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 169 | $20,222 | $14,051 | 69.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 99 | $8,962 | $5,494 | 61.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $3,364 | $3,201 | 95.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,000 | $1,183 | 59.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 19 | 19 | $859.37 | $798.51 | 92.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 21 | 21 | $427.40 | $405.14 | 94.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 19 | 19 | $386.90 | $359.67 | 93.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 15 | $375.28 | $163.25 | 43.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 320 | $63,326 | $25,899 | 40.9% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 165 | 166 | $11,002 | $6,241 | 56.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 43 | 43 | $10,191 | $5,899 | 57.9% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 129 | 131 | $8,489 | $4,866 | 57.3% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 38 | 38 | $3,002 | $2,480 | 82.6% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 48 | 48 | $3,057 | $1,724 | 56.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 107 | 155 | $7,285 | $1,628 | 22.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 65 | 83 | $6,225 | $1,380 | 22.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 19 | $2,489 | $1,233 | 49.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 78 | 83 | $4,980 | $1,100 | 22.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 64 | 102 | $4,488 | $990.42 | 22.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 91 | 107 | $3,745 | $824.82 | 22.0% |
About Dr. Jacqueline Champlain, MD
Dr. Jacqueline Champlain, MD is a Family Medicine healthcare provider based in Elgin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1497049209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacqueline Champlain, MD has received a total of $116,428 in payments from pharmaceutical and medical device companies, with $9,240 received in 2024. These payments were reported across 492 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($84,454).
As a Medicare-enrolled provider, Champlain has provided services to 2,676 Medicare beneficiaries, totaling 3,741 services with total Medicare billing of $153,605. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Elgin, TX
- Active Since 06/09/2011
- Last Updated 12/26/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497049209
Products in Payments
- Rybelsus (Drug) $39,876
- Ozempic (Drug) $27,371
- RYBELSUS (Drug) $24,793
- SOLIQUA 100/33 (Biological) $9,615
- Victoza (Drug) $7,028
- TOUJEO (Biological) $1,456
- JARDIANCE (Drug) $627.83
- TRELEGY ELLIPTA (Drug) $302.01
- Kerendia (Drug) $213.64
- TOUJEO (Drug) $139.24
- TRULICITY (Drug) $129.95
- SOLIQUA (Drug) $125.00
- TRINTELLIX (Drug) $122.34
- Descovy (Drug) $121.31
- FARXIGA (Drug) $109.08
- NURTEC ODT (Drug) $85.14
- Tresiba (Drug) $78.53
- VRAYLAR (Drug) $78.17
- PREVNAR 20 (Biological) $71.93
- LINZESS (Drug) $70.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Elgin
James Martin, Md, MD
Family Medicine — Payments: $14,066
Family Medicine $14,066
Diana Solis, Md, MD
Family Medicine — Payments: $9,448
Family Medicine $9,448
Dr. Savitha Susarla, D.o, D.O
Family Medicine — Payments: $8,988
Family Medicine $8,988
Gregory Winters, Md, MD
Family Medicine — Payments: $5,336
Family Medicine $5,336
Dr. Ulysses Magnanao, D.o, D.O
Family Medicine — Payments: $4,920
Family Medicine $4,920
Syed Quadri, M.d, M.D
Family Medicine — Payments: $4,018
Family Medicine $4,018